Statistics from Altmetric.com
Randomised controlled trial.
Six weeks (treatment period only).
One outpatient and one inpatient clinic at a university hospital, Cantabria, Spain; enrolment February 2001 to February 2005.
182 adults (15–60 years old; 93% antipsychotic naive) with non-affective psychotic disorder (DSM-IV) and psychotic symptoms of moderate severity or greater (Scale for the Assessment of Positive Symptoms). Exclusions: DSM-IV mental retardation, DSM-IV drug dependence, or ⩾6 weeks’ total lifetime adequate antipsychotic treatment.
Haloperidol (3–9 mg/day; mean modal dose 5.4 mg/day) risperidone (3–6 mg/day; mean modal dose 4 mg/day), …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.